GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » EBITDA Margin %

Cantourage Group SE (XTER:HIGH) EBITDA Margin % : 4.67% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cantourage Group SE's EBITDA for the six months ended in Jun. 2023 was €0.03 Mil. Cantourage Group SE's Revenue for the six months ended in Jun. 2023 was €0.60 Mil. Therefore, Cantourage Group SE's EBITDA margin for the quarter that ended in Jun. 2023 was 4.67%.


Cantourage Group SE EBITDA Margin % Historical Data

The historical data trend for Cantourage Group SE's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE EBITDA Margin % Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
- -104.53 -15.51 4.81

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
EBITDA Margin % Get a 7-Day Free Trial - - - 4.81 4.67

Competitive Comparison of Cantourage Group SE's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EBITDA Margin % falls into.



Cantourage Group SE EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cantourage Group SE's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=0.029/0.603
=4.81 %

Cantourage Group SE's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.028/0.599
=4.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cantourage Group SE EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines